Skip to main content
. 2013 Nov;195(3):899–913. doi: 10.1534/genetics.113.154393

Table 1. Phenotypic strength of selected vab-1 mutations and molecular lesions.

Allele Mutagen Embryonic lethality (%) Larval lethality (%) Adult, Vab (%) Adult, non-Vab (%) WT sequence Mutant sequence Effect
Strong
 e2027(null) SPO 58.2 31.3 8.9 2.5 74-bp deletion, removing first 7 bp of exon 5
 e721 EMS 58.2 29.3 11.4 1.0 ACG ATG ATG codon in 5′-UTR
 ok1699 UV 53.4 20.7 23.9 2.0 1016-bp deletion of exon 5
 ju220 UV/TMP 45.4 15.0 34.6 5.1 Exon 1 rearrangement
 ju307 EMS 41.9 27.2 29.1 1.8 GAA AAA E62K
Intermediate
 ju275 EMS 18.0 7.3 65.0 9.8 GCG GTG A245V
Weak
 zd118 EMS 13.8 7.5 24.6 54.0 TGG TGA W934opal
 ju426 EMS 13.6 2.1 55.3 28.9 TGG TGA W934opal
 e118(kd) EMS 10.1 8.6 45.6 35.8 326-bp deletion in exon 10
 ju306 ENU 1.7 1.4 32.4 64.4 GTC GAC V220D
 qa2211 EMS 1.5 1.1 18.7 78.7 GGA GAA G256E

Three new alleles were characterized as genetically null based on phenotypic strength and molecular lesions: ju220 is a rearrangement of unknown structure that affects exon 1, encoding the start codon and signal sequence; ok1699 is a 1016-bp deletion of exon 5, which encodes part of the ephrin binding domain and the cysteine-rich domain in the extracellular domain; and ju307 results in the same missense alteration (E62K) as the previously described ju8 (George et al. 1998). The previously unsequenced null allele e721 creates a premature ATG in the vab-1 5′-untranslated region; translation from this out-of-frame upstream ORF likely interferes with translation from the native vab-1 ATG. Three new alleles result in missense alterations in the extracellular cysteine-rich domain, providing mutational evidence for the importance of this domain.